Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
03/2012
03/15/2012CA2809624A1 Novel piperazine analogs as broad-spectrum influenza antivirals
03/15/2012CA2808724A1 1,5-diaryl-2-alkylpyrrole-3-substituted nitro esters, selective cox-2 inhibitors and nitric oxide donors
03/14/2012EP2428506A1 Heterocyclic substituted acardite derivates and use thereof
03/14/2012EP2427429A1 Carboxamide compounds and their use as calpain inhibitors
03/14/2012EP2427426A1 Insecticidal compounds
03/14/2012EP2427425A2 Tetracycline compounds
03/14/2012EP2427194A1 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/14/2012EP1928872B1 Novel sulphonylpyrroles as inhibitors of hdac
03/14/2012CN101528687B Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
03/13/2012US8134146 Heterocyclic radical or diradical, the dimers, oligomers, polymers, dispiro compounds and polycycles thereof, the use thereof, organic semiconductive material and electronic or optoelectronic component
03/13/2012US8134005 Preparation and use of magnesium amides
03/08/2012WO2012031090A2 Small molecule inhibitors of ebola and lassa fever viruses and methods of use
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012028959A1 Agonists of neurotrophin receptors and their use as medicaments
03/08/2012WO2012028563A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012WO2012027825A1 Method of treating dopamine-related neuropsychiatric disorders
03/08/2012WO2011143522A3 Enhanced homing and engraftment of hematopoietic stem cells using boroproline compounds
03/08/2012US20120059161 Compounds and methods for treating aids and hiv infections
03/08/2012US20120059040 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012CA2809774A1 Agonists of neurotrophin receptors and their use as medicaments
03/08/2012CA2809222A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012CA2809112A1 Cyclic amide derivative
03/07/2012EP2425831A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
03/07/2012EP2424854A2 Compositions and methods for treatment of cardiovascular disease
03/07/2012EP2424839A2 A process for the preparation of lasofoxifene tartrate
03/07/2012EP2424838A1 Pesticidal arylpyrrolidines
03/07/2012EP1572641B1 Method for production of theR,R (or S,S) configuration of glycopyrronium stereoisomers
03/07/2012EP1352650B1 Inhibitors against the production and release of inflammatory cytokines
03/07/2012CN101891668B L-prolinamide derivative, preparation method and application of same
03/07/2012CN101432263B Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/06/2012US8129547 Anticoagulation of human blood ex vivo
03/06/2012US8129535 Alkyl ether derivatives or salts thereof
03/06/2012US8129524 Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129372 Compounds having NPY Y5 receptor antagonistic activity
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/01/2012WO2012026886A1 Chalcone structure fluorescence dye for embryonic stem cell probe
03/01/2012WO2012025646A1 Maleimide‑furanyl compounds that can be used in a general method for preparing maleimide‑oligonucleotide derivatives
03/01/2012WO2012025587A1 Process for the manufacture of tmhq
03/01/2012WO2012025502A1 New process for the preparation of intermediates useful for the manufacture nep inhibitors
03/01/2012WO2012025164A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2011143521A3 Enhanced homing and engraftment of hematopoietic stem cells using cd26 inhibitors
03/01/2012US20120053200 Bace 2 inhibitors
03/01/2012US20120053192 Heterocyclic Substituted Acardite Derivate and Application Thereof
03/01/2012US20120053181 Pyrrolidine-derived beta 3 adrenergic receptor agonists
03/01/2012CA2807738A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012CA2806501A1 New process for the preparation of intermediates useful for the manufacture nep inhibitors
02/2012
02/29/2012EP2423176A1 Carboxylic acid compound
02/29/2012EP2421826A1 Proline derivatives as cathepsin inhibitors
02/29/2012EP2421375A2 Chemical and biological agents for the control of molluscs
02/29/2012EP1975158B9 Novel pyrrole derivatives with histone deacetylase inhibitor activity
02/29/2012EP1667966B1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
02/29/2012EP1606248B1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
02/29/2012EP1242471B1 Substituted group 4 metal complexes, catalysts and olefin polymerization process
02/29/2012CN102365282A 9H-pyrrolo[2,3-B: 5,4-C'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102363607A Method for synthesizing maleimide by using strongly acidic room-temperature ionic liquid as medium
02/29/2012CN101544606B Malononitrile compound and use thereof
02/28/2012US8124792 Compounds and methods for rapid labeling of N-glycans
02/28/2012US8124790 Preparation process useful in synthesis of atorvastatin
02/23/2012WO2012024100A2 Process for preparing aminocyclohexyl ether compounds
02/23/2012WO2012022994A1 Preparation process of vildagliptin
02/23/2012US20120046337 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
02/23/2012US20120046336 Methods and compositions for improving cognitive function
02/23/2012US20120046335 Solid states of atorvastatin potassium
02/23/2012US20120046276 Tuberculosis treatment using pleuromutilin derivatives
02/23/2012US20120045848 Pyrenyloxysulfonic acid fluorescent agents
02/23/2012US20120045509 Modified release compositions for dpp-iv inhibitors
02/23/2012CA2808098A1 Process for preparing aminocyclohexyl ether compounds
02/22/2012EP2420488A1 Novel crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same
02/22/2012EP2420487A1 Novel method for producing optically active pyrrolidine compound
02/22/2012EP2419431A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
02/22/2012EP2419413A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
02/22/2012EP2419405A1 3-(phenoxypyrrolidin-3-yl-methyl)heteroaryl, 3-(phenylpyrrolidin-3-ylmethoxy)heteroaryl, and 3-(heteroarylpyrrolidin-3-ylmethoxy)heteroaryl compounds
02/22/2012EP2419404A1 Anti-viral compounds
02/22/2012EP1660440B1 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
02/22/2012EP1421827B1 Organic light emitting devices having carrier blocking layers comprising metal complexes
02/22/2012EP0986384B1 Inhibitors of protein isoprenyl transferases
02/22/2012CN102361853A Toluidine sulfonamides and their use
02/22/2012CN101941932B 1,3-双(4-马来酰亚胺基-2-三氟甲基苯氧基)苯的制备方法 Preparation of 1,3-bis (4-maleimide-2-trifluoromethylphenoxy) benzene
02/21/2012US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
02/21/2012US8119818 Functionalized N-substituted pyrrolidonium ionic liquids
02/21/2012US8119817 Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
02/21/2012US8119664 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
02/21/2012US8119570 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
02/21/2012CA2508845C Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
02/21/2012CA2508618C Tetrahydro-naphthalene derivatives
02/21/2012CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
02/21/2012CA2248800C Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
02/16/2012WO2012021712A1 Tetracycline analogs
02/16/2012WO2012020130A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012US20120041212 Process for the preparation of pregabalin
02/16/2012US20120041178 Coenzyme Q10 Nanoparticles, Preparation Method Thereof and Composition Containing Said Nanoparticles
02/16/2012US20120041025 Dihydrolipoic Acid Derivatives Comprising Nitric Oxide and Therapeutic Uses Thereof
02/16/2012US20120041001 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
02/16/2012US20120040960 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
02/16/2012DE102011080762A1 Processing N-vinylpyrrolidone, comprises reacting 2-pyrrolidone with acetylene, obtaining distillation in separation of N-vinylpyrrolidone residue and synthesis of 2-pyrrolidone residue, supplying evaporator and separating 2-pyrrolidone
02/16/2012CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/15/2012EP2418194A1 Process for the preparation of pregabalin
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 404